AI Insight: The Clorox Company’s current price at $106.41 is significantly below the PERT-weighted fair value of $191.53, indicating potential undervaluation with an 80% implied upside. Monte Carlo results show high volatility (170% coefficient of variation) but limited downside risk (6.2%), reflecting growth uncertainty amid weak profitability (1/5) and leverage scores (1/5). Strong efficiency contrasts with fair liquidity and low growth, suggesting valuation optimism hinges on future performance improvements.